Digital Genome Market New Application of Potential Growth and New Challenges

The digital genome consists of a complete digital collection of DNA material that occurs within an organism or a cell. It's a simpler method to collect genetic data concerning hereditary disorders and is used extensively by geneticists for a closer look at potential genetic illnesses. It was first intended to be a tool of diagnosis but has evolved into a powerful research tool.

The digital genome consists of a complete digital collection of DNA material that occurs within an organism or a cell. It's a simpler method to collect genetic data concerning hereditary disorders and is used extensively by geneticists for a closer look at potential genetic illnesses. It was first intended to be a tool of diagnosis but has evolved into a powerful research tool.

Exclusive offer!!! Purchase the report at a discounted rate!!!

Flat Instant discount of US$ 2000

Buy This Complete A Business Report:
https://www.coherentMarketinsights.com/promo/buynow/136

The growing popularity of the human genome projects is a prime factor fueling the market growth of the digital genome. According to Forbes, by 2025, it’s projected that 100 million genomes will be sequenced. Increasing funding for genomics is another major factor in augmenting the market growth.

Moreover, growing development in the field of biotechnology due to rising healthcare needs and increasing investment by the government is again driving the market growth. Additionally, the growing demand for personalized medicines coupled with the penetration of new players and start-ups across developing economies is also projected to foster market growth. Furthermore, the increasing prevalence of the chronic disease is further projected to propel the market growth of the digital genome.

For instance, in October 2019, Inscripta, Inc., announced the launch of the Onyx™ Digital Genome Engineering platform. It is a fully automated benchtop instrument for genome-scale engineering. The CRISPR-mediated, massively parallel platform — which includes software, consumables, instrument, and assays — enables researchers to engineer microbial libraries containing the full breadth and scope of possible edit types, in their own labs.

Key Developments:

In August 2020, Ancestry has launched an AncestryHealth powered by Next Generation Sequencing,” the tool can screen for genes associated with breast cancer, heart disease, colon cancer, and blood disorders.

in October 2019, MGI has launched its new one-stop sequencing solution, including the portable "express" sequencing system DNBSEQ E series, the modular "digital biolab" DNBelab D series for use with the sequencing system, and a new single "cell" DNBelab C series, a handheld single-cell laboratory that can fit into a pocket.

In February 2020, Twist Bioscience launches twist targeted methylation sequencing solution to study methylation pattern changes in a wide range of research fields including cancer, epigenetics, and non-invasive prenatal testing

For Customization on this Report @ https://www.coherentmarketinsights.com/insight/request-customization/136

Major Market Competitors

Illumina, Inc., PerkinElmer, Inc., Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Limited, Nanostring Technologies, Inc., IBM Corporation, Google LLC, Amazon.com, Inc., Deep Genomics, Deep Genomics, Deep Genomics, Desktop Genetics Ltd., and Ancestry.com LLC.

Market Segmentation

Global Digital Genome Market, By Product Type:
Sequencer & Analyzers
Reagents & Kits
Sequencing & Analysis Software
Global Digital Genome Market, By Application:
Clinical
Reproductive Health
Oncology
Others
Forensics
Drug Discovery and Development
Other Applications
Global Digital Genome Market, By End User:
Hospitals
Diagnostic Centers
Research Institutes
Biotechnology and Pharmaceutical Companies
Others

Download PDF Sample Report @
https://www.coherentmarketinsights.com/insight/request-sample/136

Covid-19 Impact:

The COVID-19 pandemic has exacerbated the world’s healthcare challenges. Social distancing and shutdowns have accelerated adoption of digital technologies in the healthcare sector. Our updated reports have answers to various concerns in the global Digital Genome market caused due to the pandemic.

Contact us:
Mr. Shah
Senior Client Partner – Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.